Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Partial”

374 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 374 results

Post-approval studies (Phase 4)Ended earlyNCT00215215
What this trial is testing

Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

Who this might be right for
Epilepsies, Partial
Cyberonics, Inc. 360
Not applicableEnded earlyNCT01648959
What this trial is testing

Intra Cranial EEG Activity During Dexmedetomidine Sedation

Who this might be right for
Complex Partial Seizures
University Health Network, Toronto 5
Large-scale testing (Phase 3)Study completedNCT00700310
What this trial is testing

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 712
Testing effectiveness (Phase 2)Study completedNCT01179854
What this trial is testing

Remegal Different Doses in Patients With Refractory Partial Seizures

Who this might be right for
Drug SafetyNormal Drug ToleranceSelf Efficacy
Valexfarm 60
Large-scale testing (Phase 3)Study completedNCT00566254
What this trial is testing

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Who this might be right for
Epilepsy; Paediatric Partial Onset Seizures
Eisai Inc. 207
Large-scale testing (Phase 3)Active Not RecruitingNCT05067634
What this trial is testing

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 140
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Post-approval studies (Phase 4)Ended earlyNCT02090998
What this trial is testing

Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines

Who this might be right for
Transformed MigraineChronic Daily Headache
Rutgers, The State University of New Jersey 10
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Testing effectiveness (Phase 2)Study completedNCT02495844
What this trial is testing

UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma S.P.R.L. 55
Large-scale testing (Phase 3)Looking for participantsNCT07594119
What this trial is testing

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

Who this might be right for
Focal SeizureEpilepsyFocal Epilepsy
Rapport Therapeutics Inc. 312
Large-scale testing (Phase 3)Study completedNCT00150800
What this trial is testing

This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment

Who this might be right for
Epilepsy
UCB PHARMA Inc. (US) 668
Large-scale testing (Phase 3)Study completedNCT02124564
What this trial is testing

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 19
Large-scale testing (Phase 3)Study completedNCT00160628
What this trial is testing

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Who this might be right for
Epilepsy, Partial
UCB Pharma 100
Not applicableStudy completedNCT02946151
What this trial is testing

Subcutaneous EEG in Epilepsy

Who this might be right for
Temporal Lobe Epilepsy
Zealand University Hospital 10
Not applicableStudy completedNCT01657084
What this trial is testing

Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask

Who this might be right for
Epilepsy
University of Aarhus 10
Large-scale testing (Phase 3)Ended earlyNCT01668654
What this trial is testing

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Who this might be right for
Epilepsy
GlaxoSmithKline 4
Not applicableStudy completedNCT02304029
What this trial is testing

Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy

Who this might be right for
Epileptic Seizures
Assistance Publique Hopitaux De Marseille 78
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Large-scale testing (Phase 3)Study completedNCT00151879
What this trial is testing

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma 160
Load More Results